When you or a loved one is facing what appears to be a terminal illness treatment decisions can be difficult. Not only do you often have to learn a lot to truly give informed consent to the available treatments, but in the case of experimental treatments even more issues arise. The experimental nature of these treatments means that there is no guarantee that they will work and no guarantee that they will not make your situation even worse than it already is, but on the other hand such a treatment may present the only chance there is of recovery.
Some patients are pushed into these treatments and medications without truly understanding the consequences while others who know what they are getting into are denied access to potentially life saving or lengthening treatment. The red tape patients and their doctors have to go through to get access to these treatments can be prohibitive. This conflict is real and difficult to resolve. In light of it, the Food and Drug Administration (FDA) has now announced that it will make access to these treatments easier for patients.
FDA Announces New Policy